Is Medical Cannabis on the NHS the Same as CBD Oil from Shops?

The landscape of cannabis-based products in the UK has become increasingly complex in recent years. With growing public interest and shifting legislation, many wonder: is medical cannabis on the NHS the same as the cannabidiol (CBD) oil you can buy from health shops or online? The short answer is no, but the differences go beyond just who sells it. This post unpacks what changed after the 2018 rescheduling, how NHS funding and legal prescribing rules work, who can prescribe these products, and why the NHS remains cautious about unlicensed cannabis-based medicines.

For those exploring options or seeking more information, useful tools like medicalcannabis.co.uk provide clinic comparisons, while releaf.co.uk offers detailed explainer guides on cannabis-based products for medicinal use.

2018 Rescheduling: What Changed for Cannabis-Based Products?

In November 2018, the UK government made a landmark decision to reschedule cannabis-based products for medicinal use (often abbreviated as CBPMs). Before this change, these products were classified alongside controlled drugs making legal medical prescribing essentially impossible. The rescheduling meant:

Specialist doctors, such as neurologists or palliative care consultants, could now prescribe these products legally in the UK.
Patients with specific conditions could potentially access licensed cannabis-derived or synthetic medicines on prescription.
The reschedule did not make all cannabis or CBD products legal or freely prescribable – strict rules and limitations still apply.

This was a progressive move aimed at giving patients access to potentially beneficial treatments like Epidyolex (containing cannabidiol, or CBD) for rare epilepsy syndromes, or Sativex for multiple sclerosis spasticity. However, it's important to understand that being legally prescribable is not the same as being widely prescribed or routinely funded by the NHS.

The Legal Prescribing Versus NHS Funding Divide

Here is where confusion often arises. To cut through the jargon: just because a cannabis-based medicine is legal to prescribe, it does not mean the NHS will pay for it or routinely supply it.

Legal Prescribing

Under the 2018 rescheduling:

Doctors on specialist registers can prescribe CBPMs to patients who meet strict criteria.
Products prescribed may be licensed medicines (e.g. Sativex) or unlicensed formulations prepared under certain conditions.
Prescriptions are typically via specialist clinics, given the complexities and monitoring needed.

NHS Funding

Funding depends on a product’s approval by NICE (National Institute for Health and Care Excellence) or local Clinical Commissioning Groups (CCGs). Currently:

Most cannabis-based products for medicinal use are not routinely funded by the NHS.
Exceptions exist, e.g., Epidyolex for rare epilepsy combined with clobazam, where evidence supports its use and NICE has given guidance.
Patients often face high costs for privately prescribed medical cannabis, since NHS funding routes are limited.

In short, a cannabis product being legal to prescribe does not guarantee NHS access or free supply. This distinction is key when comparing with CBD oils from shops.

Specialist-Only Prescribing Rules

Another major difference is who is permitted to prescribe medical cannabis. The 2018 law clarified that only specialists on the General Medical Council’s Specialist Register https://smoothdecorator.com/how-can-i-spot-overconfident-medical-cannabis-marketing-in-the-uk/ for certain fields can prescribe CBPMs for medicinal use. This is because:

Cannabis-based medicines are complex, with variable formulations, dosing regimens, and unclear long-term safety profiles.
Specialists have the expertise to manage side effects, monitor outcomes, and assess interactions with other medications (e.g., cannabidiol can interact with clobazam, an epilepsy drug).
General practitioners (GPs) do not currently have prescribing rights for CBPMs, meaning patients must usually be referred to a specialist clinic.

This specialist-only rule serves as a safeguard but also contributes to limited NHS availability and creates barriers to access.

Unlicensed Cannabis-Based Medicines and NHS Caution

It is important to address the role of unlicensed cannabis-based medicines. These are custom-made or imported products https://highstylife.com/how-do-i-find-a-legit-medical-cannabis-clinic-in-the-uk/ that do not hold a formal UK marketing authorisation but can sometimes be prescribed when licensed options are unsuitable or unavailable.

The NHS is generally cautious with these products because:

Quality, dosing, and formulation vary widely between unlicensed preparations.
Robust clinical evidence is often lacking compared to licensed medicines.
NHS guidelines recommend unlicensed CBPM prescribing only in exceptional circumstances after thorough assessment.

As a result, unlicensed cannabis medicines are rarely funded by the NHS and tend to be accessed through private clinics or out-of-pocket purchases. This contrasts with many CBD oils sold in shops, which are marketed as food supplements, not medicines.

So, Is Medical Cannabis on the NHS the Same as CBD Oil from Shops?

Having covered the legal and regulatory landscape, let's directly compare the two:

Feature Medical Cannabis on the NHS CBD Oil from Shops Legal Status Prescription-only medicine (Cannabis-based products for medicinal use) rescheduled in 2018; prescribed by specialists Legal as food supplements; no prescription; widely available online and in health shops NHS Funding Rare and limited; e.g. Epidyolex for epilepsy with clobazam may be NHS-funded under strict criteria; most others not funded Not funded; purchased privately by consumers Product Regulation Licensed medicines or specialist unlicensed products with regulated manufacturing standards Less regulation; must contain less than 0.2% THC; variable quality standards Prescribing Authority Specialist doctors only (e.g., neurologists); GPs cannot prescribe No prescribing involved; sold as consumer products Medical Indications Specific conditions with evidence (e.g., epilepsy, MS spasticity); decision based on specialist assessment Marketed for general wellness; claims not medically verified; cannot legally claim to treat diseases Monitoring & Safety Medical oversight; interaction checking (e.g., cannabidiol + clobazam interaction) No medical supervision; users self-administer

Understanding Price Examples

One point not often discussed is cost. As of now, no specific prices for NHS medical cannabis prescriptions were publicly stated in government or NHS documents we reviewed. Prices for private consultations and cannabis-based prescriptions vary widely and can be explored via sites like medicalcannabis.co.uk, where clinics list fees.

CBD oils from shops are typically cheaper but beware that quality, cannabinoid content, and labelling vary, and these products do not replace licensed medicinal alternatives.

What Should Patients Take Away?

Medical cannabis prescribed on the NHS is a highly regulated, specialist-only treatment option, not equivalent to over-the-counter CBD oils.
NHS access is limited and cautious, reflecting evidence gaps and safety considerations. Be wary of clinics or claims implying easy NHS access.
CBD oils sold in shops are legal supplements but are NOT medicines, cannot be prescribed, and do not guarantee consistent quality or dosing.
If considering medical cannabis, consult a specialist familiar with UK prescribing rules rather than self-medicating with shop-bought CBD oil.